WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

A CASE STUDY ON PNEUMONIA

D. Nagarjuna, S. Neelima, T. Kalyani, G. Y. Srawan Kumar*, D. R. Brahma Reddy and Dr. Sudeena

Abstract

Pneumonia is an infection/inflammation in one or both lungs. It can be caused by bacteria, viruses, or fungi. This is a case report of Bilateral Pneumonia of which 41 year male patient was admitted in hospital with illness of fever with chills, cough with expectoration, wheeze, and chest pain. His Past medical history was found to be COPD since 3 years. Past medication history was observed to be Inhalational therapy. Social history convey that he is an alcoholic and smoker since 10 years. On Physical examination body temperature was 102°F. Respiratory rate is 24 CPM. On systemic examination Diagnosis was done with chest x-ray detected white patches on both lungs. Treatment started by giving Antibiotics through IV that is Injection. Ceftriaxone, Inj. Metronidazole, Inj. Amikacin. Nebulization with duolin and budecort. And orally through Tab. Paracetamol. After continuing the same medication for 4 more days the patient symptoms of febrile and chest pain was relieved. So, the patient was recovered and discharged.

Keywords: Bilateral pneumonia, Past medical history, Case report, Chest x-ray, Treatment, Diagnosis, Injection.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More